Tierra Biosciences Launches First-Ever Online Protein Ordering Platform for Synthetic Biology Protein Engineering
Sourcing thousands of proteins for research and development
Tierra Biosciences announced the launch of the Tierra Protein Platform, an industry-first eCommerce portal that allows customers to get custom proteins synthesized, validated, and shipped to them in just a few clicks. Tierra’s platform provides a faster, more convenient solution than traditional methods for sourcing thousands of proteins for research and development.
Symbolic image
pixabay.com
“The next major biological frontier after genomics is proteins, given their diverse form and function, from converting carbon dioxide to starch to fighting infections in our body,” said Zachary Sun, Ph.D., co-founder and Chief Scientific Officer of Tierra. “However, there is a lack of expedient research tools and ordering platforms for protein engineers, which can create significant time and cost bottlenecks for critical synthetic biology research.
“We specifically developed the Tierra Protein Platform to solve these bottlenecks and give everyone a convenient way to access a diverse range of proteins — even ones that are impossible to produce in common laboratory cells,” continued Dr. Sun. “We believe this will significantly lower the barrier-to-entry for protein synthesis, thereby enabling researchers and moving the synthetic biology field forward.”
Customers can enter up to 10,000 digital protein sequences into the company’s online portal. Tierra’s proprietary artificial intelligence (AI) system then analyzes the input to assess whether the proteins contain regions incompatible with the manufacturing system. From there, the company uses a cell-free manufacturing process to synthesize the final proteins, which are then shipped after extensive quality control and experimental validation. By taking the protein-synthesizing elements out of living bacteria, reliance on these organisms is eliminated, and efficiency and throughput are substantially increased.
Tierra’s disruptive, scalable protein synthesis platform has already been operating at a commercial scale, serving customers across industries and geographies working on everything from petrochemical-free fashion/textiles and cruelty-free cosmetics to novel flavors and aromas for FoodTech. Salesforce, one of the company’s earliest customers, approached Tierra to synthesize and test over 500 synthetic proteins.
“It is exciting to consider what Tierra will enable in the field of computational biology,” said Ali Madani, Senior Research Scientist at Salesforce. “Our work had generated thousands of computationally designed proteins, but we had no simple way to empirically validate them. Tierra’s platform was the missing piece to our research stack, providing invaluable data and insights that have carried our research forward faster than would otherwise be possible.”
Other news from the department business & finance
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.
Last viewed contents
Lethal combination: Drug cocktail turns off the juice to cancer cells
Rice wins NIH funding for oral-cancer test - Grand Opportunity grant funds rapid saliva test using lab-on-a-chip
Agilent Technologies Presents Thought Leader Award to Lipidomics Expert Dr. Jules Griffin - Cambridge Researcher to Further Studies of Obesity, Fatty Liver Disease
Plant Biotechnology Has Gone Global With Research and Production Underway in 63 Countries - Biotech Crops Generate $27.5 Billion in Value in United States
Laboratorios VM Ltda. - Bogotá, Colombia
Fast-Growing Market for SNPs Products Continues to Grow
Genmab Acquires Antibody Assets from iDD Biotech
Strand Genomics changes corporate identity to Strand Life Sciences
TET Systems and Novo Nordisk sign license agreement